|
Status |
Public on Dec 07, 2016 |
Title |
staud-00261: LYM324 |
Sample type |
RNA |
|
|
Source name |
diffuse large-B-cell lymphoma
|
Organism |
Homo sapiens |
Characteristics |
dlbcl sample (lym number): 324 analysis set: Training follow-up (years): 6.5 status at follow-up: Alive subgroup: GCB ipi group: Medium germinal center b cell signature: 1.14 lymph node signature: 0.1 proliferation signature: 0.19 bmp6: 0.34 mhc class ii signature: 1.05 outcome predictor score: -0.53
|
Extracted molecule |
total RNA |
Extraction protocol |
See mage-tab files linked to series entry for additional details
|
Label |
Cy5/Cy3
|
Label protocol |
See mage-tab files linked to series entry for additional details
|
|
|
Hybridization protocol |
See mage-tab files linked to series entry for additional details
|
Scan protocol |
See mage-tab files linked to series entry for additional details
|
Data processing |
See mage-tab files linked to series entry for additional details
|
|
|
Submission date |
Dec 06, 2016 |
Last update date |
Dec 07, 2016 |
Contact name |
Mervi Heiskanen |
E-mail(s) |
mervi.heiskanen@nih.gov
|
Phone |
2402765175
|
Organization name |
NCI
|
Department |
CBIIT
|
Street address |
9609 Medical Center Drive, 1W378
|
City |
Rockville |
State/province |
MD |
ZIP/Postal code |
20850 |
Country |
USA |
|
|
Platform ID |
GPL22757 |
Series (1) |
GSE90953 |
caArray_staud-00261: The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma |
|